These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 27636112)

  • 1. Overview of Critical Parameters for the Design and Execution of a High-Throughput Screen for Allosteric Ligands.
    Alt A
    Curr Protoc Pharmacol; 2016 Sep; 74():9.20.1-9.20.23. PubMed ID: 27636112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mapping Cannabinoid 1 Receptor Allosteric Site(s): Critical Molecular Determinant and Signaling Profile of GAT100, a Novel, Potent, and Irreversibly Binding Probe.
    Laprairie RB; Kulkarni AR; Kulkarni PM; Hurst DP; Lynch D; Reggio PH; Janero DR; Pertwee RG; Stevenson LA; Kelly ME; Denovan-Wright EM; Thakur GA
    ACS Chem Neurosci; 2016 Jun; 7(6):776-98. PubMed ID: 27046127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computational Advances for the Development of Allosteric Modulators and Bitopic Ligands in G Protein-Coupled Receptors.
    Feng Z; Hu G; Ma S; Xie XQ
    AAPS J; 2015 Sep; 17(5):1080-95. PubMed ID: 25940084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of allosteric modulation: Exploring the binding kinetics of glutamate and other orthosteric ligands of the metabotropic glutamate receptor 2.
    Doornbos MLJ; Vermond SC; Lavreysen H; Tresadern G; IJzerman AP; Heitman LH
    Biochem Pharmacol; 2018 Sep; 155():356-365. PubMed ID: 30028996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the novel positive allosteric modulator, LY2119620, at the muscarinic M(2) and M(4) receptors.
    Croy CH; Schober DA; Xiao H; Quets A; Christopoulos A; Felder CC
    Mol Pharmacol; 2014 Jul; 86(1):106-15. PubMed ID: 24807965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How Do Modulators Affect the Orthosteric and Allosteric Binding Pockets?
    Chen CJ; Jiang C; Yuan J; Chen M; Cuyler J; Xie XQ; Feng Z
    ACS Chem Neurosci; 2022 Apr; 13(7):959-977. PubMed ID: 35298129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a high-throughput calcium flux assay for identification of all ligand types including positive, negative, and silent allosteric modulators for G protein-coupled receptors.
    Noblin DJ; Bertekap RL; Burford NT; Hendricson A; Zhang L; Knox R; Banks M; O'Connell J; Alt A
    Assay Drug Dev Technol; 2012 Oct; 10(5):457-67. PubMed ID: 22746835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PAM-Antagonists: A Better Way to Block Pathological Receptor Signaling?
    Kenakin T; Strachan RT
    Trends Pharmacol Sci; 2018 Aug; 39(8):748-765. PubMed ID: 29885909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allosteric modulators of G-protein-coupled receptors.
    May LT; Christopoulos A
    Curr Opin Pharmacol; 2003 Oct; 3(5):551-6. PubMed ID: 14559102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategies for the identification of allosteric modulators of G-protein-coupled receptors.
    Burford NT; Watson J; Bertekap R; Alt A
    Biochem Pharmacol; 2011 Mar; 81(6):691-702. PubMed ID: 21184747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biased allosteric agonism and modulation of metabotropic glutamate receptor 5: Implications for optimizing preclinical neuroscience drug discovery.
    Sengmany K; Singh J; Stewart GD; Conn PJ; Christopoulos A; Gregory KJ
    Neuropharmacology; 2017 Mar; 115():60-72. PubMed ID: 27392634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Modeling Study of a Receptor-Orthosteric Ligand-Allosteric Modulator Signaling Complex.
    Jiang C; He X; Wang Y; Chen CJ; Othman Y; Hao Y; Yuan J; Xie XQ; Feng Z
    ACS Chem Neurosci; 2023 Feb; 14(3):418-434. PubMed ID: 36692197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the Second Extracellular Loop of the Adenosine A1 Receptor on Allosteric Modulator Binding, Signaling, and Cooperativity.
    Nguyen AT; Vecchio EA; Thomas T; Nguyen TD; Aurelio L; Scammells PJ; White PJ; Sexton PM; Gregory KJ; May LT; Christopoulos A
    Mol Pharmacol; 2016 Dec; 90(6):715-725. PubMed ID: 27683013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allosteric "beta-blocker" isolated from a DNA-encoded small molecule library.
    Ahn S; Kahsai AW; Pani B; Wang QT; Zhao S; Wall AL; Strachan RT; Staus DP; Wingler LM; Sun LD; Sinnaeve J; Choi M; Cho T; Xu TT; Hansen GM; Burnett MB; Lamerdin JE; Bassoni DL; Gavino BJ; Husemoen G; Olsen EK; Franch T; Costanzi S; Chen X; Lefkowitz RJ
    Proc Natl Acad Sci U S A; 2017 Feb; 114(7):1708-1713. PubMed ID: 28130548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "Selective" Class C G Protein-Coupled Receptor Modulators Are Neutral or Biased mGlu
    Hellyer SD; Albold S; Wang T; Chen ANY; May LT; Leach K; Gregory KJ
    Mol Pharmacol; 2018 May; 93(5):504-514. PubMed ID: 29514854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of equilibrium binding of an orthosteric tracer and two allosteric modulators.
    Jakubík J; Randáková A; El-Fakahany EE; Doležal V
    PLoS One; 2019; 14(3):e0214255. PubMed ID: 30917186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Novel Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 5 Acting at Site Distinct from 2-Methyl-6-(phenylethynyl)-pyridine Binding.
    Butkiewicz M; Rodriguez AL; Rainey SE; Wieting J; Luscombe VB; Stauffer SR; Lindsley CW; Conn PJ; Meiler J
    ACS Chem Neurosci; 2019 Aug; 10(8):3427-3436. PubMed ID: 31132237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of selective agonists and positive allosteric modulators for µ- and δ-opioid receptors from a single high-throughput screen.
    Burford NT; Wehrman T; Bassoni D; O'Connell J; Banks M; Zhang L; Alt A
    J Biomol Screen; 2014 Oct; 19(9):1255-65. PubMed ID: 25047277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a high throughput screen for allosteric modulators of melanocortin-4 receptor signaling using a real time cAMP assay.
    Pantel J; Williams SY; Mi D; Sebag J; Corbin JD; Weaver CD; Cone RD
    Eur J Pharmacol; 2011 Jun; 660(1):139-47. PubMed ID: 21296065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-Throughput Agonist Shift Assay Development for the Analysis of M
    Homsher MF; Beshore DC; Cassaday J; Squadroni B; Mohammed E; Hartnett M; Day S; Ma L; Pechter D; Smith MD; Monsma F; Zuck P; Finley MF; Uebele VN; Hermes JD
    SLAS Discov; 2017 Sep; 22(8):1060-1066. PubMed ID: 28426939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.